(Press-News.org) Scientists have identified more than 800 markers in the blood of cancer patients that could help lead to a single blood test for early detection of many types of cancer in future, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Sunday).
This is the first time that cancer-specific blood markers have been comprehensively reviewed and identified for further clinical development. This study, by the UK Early Cancer Detection Consortium*, funded by Cancer Research UK, has analysed 19,000 scientific papers and found more than 800 biomarkers.
The aim of this research is to develop a screening test from a single blood sample for multiple cancer types. All cancers produce markers in the blood, so it could be feasible to develop a general screening test for many different forms of the disease.
In the UK, survival rates for cancer are lower than in some other western countries, part of which may be related to late diagnosis. But developing more ways to spot cancers earlier, including research into new screening technologies such as this, could help give more options for curative treatment, and save more lives in the future.
In the UK, cancer is most often detected after patients present symptoms to their doctor, with a small proportion being detected through any of the three national screening programmes for breast, bowel, and cervical cancer. This study could open the way for less invasive, new screening tests that could detect more cancers, possibly including some rare types, at an early stage when they are more likely to be treatable.
Cancer Research UK is committed to early diagnosis of cancer, importantly reducing late diagnosis and improving patients' chances of surviving long term.
Study author Professor Ian Cree, a Cancer Research UK funded scientist at the University of Warwick and University Hospital in Coventry, said: "This is a new approach to early detection and the first time such a systematic review has been done. A single blood-based screening test would be a game changer for early detection of cancer which could help make it a curable disease for many more patients. We believe that we've identified all the relevant biomarkers; the next step is working out which ones work the best for spotting cancers."
The identified biomarkers will be reviewed and categorised before they are developed further in clinical laboratory studies.
Sara Hiom, Cancer Research UK's director of early diagnosis, said: "This is an innovative and promising new approach. And although in its early stages, it shows how our increased understanding of cancers' 'markers' and new technologies are combining to offer new opportunities to detect cancer sooner. Diagnosing cancer at an early stage generally means more effective treatment and that translates into better survival. Our goal over the next 20 years is that three in four cancer patients will survive at least ten years after their diagnosis."
INFORMATION:
For media enquiries please contact Stephanie McClellan on 020 3469 5314 or, out-of-hours, the duty press officer on 07050 264 059.
Notes to editors:
*The Early Cancer Detection Consortium unites expertise from various disciplines including more than 20 universities, hospitals and commercial partners.
Abstract to the research: http://conference.ncri.org.uk/abstracts/2014/abstracts/LB003.html
About the NCRI
The National Cancer Research Institute (NCRI) is a UK-wide partnership between the government, charity and industry. Its role is to promote cooperation in cancer research.
NCRI Partners are: the Association of the British Pharmaceutical Industry (ABPI); Biotechnology and Biological Sciences Research Council; Breakthrough Breast Cancer; Breast Cancer Campaign; Cancer Research UK; Children with Cancer UK; Department of Health; Economic and Social Research Council; Leukaemia & Lymphoma Research; Ludwig Institute for Cancer Research; Macmillan Cancer Support; Marie Curie Cancer Care; Medical Research Council; Northern Ireland Health and Social Care (Research & Development Office); Prostate Cancer UK; Roy Castle Lung Cancer Foundation; Scottish Government Health and Social Care Directorates (Chief Scientist Office); Tenovus; Welsh Government (National Institute for Social Care and Health Research); Worldwide Cancer Research (formerly the Association for International Cancer Research); Wellcome Trust; and Yorkshire Cancer Research.
For more information visit http://www.ncri.org.uk
About the NCRI Cancer Conference
The National Cancer Research Institute (NCRI) Cancer Conference is the UK's major forum for showcasing the best British and international cancer research.
The Conference offers unique opportunities for networking and sharing knowledge by bringing together world-leading experts from all cancer research disciplines.
The tenth NCRI Cancer Conference is taking place from 2–5 November 2014 at the BT Convention Centre in Liverpool.
For more information visit conference.ncri.org.uk
About the NIHR
The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government's strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world. For further information, visit the NIHR website.
Step towards blood test for many cancer types
2014-11-02
ELSE PRESS RELEASES FROM THIS DATE:
JNS: Pediatrics publishes guidelines for the treatment of pediatric hydrocephalus
2014-11-01
Charlottesville, VA (November 1, 2014). The Journal of Neurosurgery Publishing Group is pleased to announce today's publication of "Pediatric hydrocephalus: systematic literature review and evidence-based guidelines," a supplement to the November issue of the Journal of Neurosurgery: Pediatrics. Authored by a volunteer task force from the pediatric neurosurgery community, the supplement offers a thorough evaluation of the current treatments for pediatric hydrocephalus as well as up-to-date evidence-based recommendations for their use.
Hydrocephalus is a condition in which ...
More penalties on the way for hospitals that treat the poor? New U-M study suggests so
2014-11-01
ANN ARBOR, Mich. – Last week, the federal government revealed that it will fine more than 2,600 hospitals in the coming year, because too many Medicare patients treated at these hospitals are ending up back in the hospital within 30 days of going home. Two new conditions have been added in this round of penalties: elective hip and knee replacement and chronic lung disease.
Now, a new University of Michigan analysis shows that penalties for chronic lung disease will have a greater impact on hospitals that care for poor and minority patients. The findings are published ...
Cancer cell fingerprints in the blood may speed up childhood cancer diagnosis
2014-11-01
Newly-identified cancer cell fingerprints in the blood could one day help doctors diagnose a range of children's cancers faster and more accurately, according to research* presented at the National Cancer Research Institute (NCRI) Cancer Conference next week.
The researchers, from the University of Cambridge and Addenbrooke's Hospital in Cambridge, found unique molecular fingerprints for 11 types of children's tumours,** which could be used to develop blood tests to diagnose these cancers.
This may eventually lead to a quicker, more accurate way to diagnose tumours, ...
Study of Chile earthquake finds new rock structure that affects earthquake rupture
2014-11-01
Researchers from the University of Liverpool have found an unusual mass of rock deep in the active fault line beneath Chile which influenced the rupture size of a massive earthquake that struck the region in 2010.
The geological structure, which was not previously known about, is unusually dense and large for this depth in the Earth's crust. The body was revealed using 3-D seismic images of Earth's interior based on the monitoring of vibrations on the Pacific seafloor caused by aftershocks from the magnitude 8.8 Chile earthquake. This imaging works in a similar way to ...
Breaking down DNA by genome
2014-10-31
New DNA sequencing technologies have greatly advanced genomic and metagenomic studies in plant biology. Scientists can readily obtain extensive genetic information for any plant species of interest, at a relatively low cost, rapidly accelerating the pace of genome sequencing.
However, since plant tissues harbor three separate genomes (nuclear, chloroplast, and mitochondrial), it can often be challenging to isolate the particular genome of interest from extracted DNA samples. Sequencing DNA containing all three genomes therefore results in a considerable amount of wasted ...
Goodbye to rainy days for US, Japan's first rain radar in space
2014-10-31
After 17 years of groundbreaking 3-D images of rain and storms, the joint NASA and Japan Aerospace Exploration Agency Tropical Rainfall Measuring Mission (TRMM) will come to an end next year. NASA predicts that science operations will cease in or about April 2015, based on the most recent analysis by mission operations at NASA's Goddard Space Flight Center, Greenbelt, Maryland.
On July 8, 2014, pressure readings from the fuel tank indicated that TRMM was near the end of its fuel supply. As a result, NASA ceased station-keeping maneuvers that would keep the satellite at ...
Tracking a gigantic sunspot across the Sun
2014-10-31
An active region on the sun – an area of intense and complex magnetic fields – rotated into view on Oct. 18, 2014. Labeled AR 12192, it soon grew into the largest such region in 24 years, and fired off 10 sizable solar flares as it traversed across the face of the sun. The region was so large it could be seen without a telescope for those looking at the sun with eclipse glasses, as many did during a partial eclipse of the sun on Oct. 23.
"Despite all the flares, this region did not produce any significant coronal mass ejections," said Alex Young a solar scientist ...
Massive geographic change may have triggered explosion of animal life
2014-10-31
AUSTIN, Texas— A new analysis of geologic history may help solve the riddle of the "Cambrian explosion," the rapid diversification of animal life in the fossil record 530 million years ago that has puzzled scientists since the time of Charles Darwin.
A paper by Ian Dalziel of The University of Texas at Austin's Jackson School of Geosciences, published in the November issue of Geology, a journal of the Geological Society of America, suggests a major tectonic event may have triggered the rise in sea level and other environmental changes that accompanied the apparent ...
Scientists replicate the tide with two buckets, aquarium tubing, and a pump
2014-10-31
Rachel MacTavish is growing salt marsh plants in microcosms that replicate the tide. She assembled them in an outdoor greenhouse at the Sapelo Island National Estuarine Research Reserve in Georgia, USA, with buckets from a hardware store, aquarium tubing, and pumps. Her tidal simulation units could be an important tool for preserving and restoring environmentally important wetlands, because they enable researchers to investigate tidal marsh plant growth in a controlled setting.
"Tidal wetlands are often influenced by many factors, and controlled experiments allow researchers ...
Are my muscular dystrophy drugs working?
2014-10-31
INDIANAPOLIS -- People with muscular dystrophy could one day assess the effectiveness of their medication with the help of a smartphone-linked device, a new study in mice suggests. The study used a new method to process ultrasound imaging information that could lead to hand-held instruments that provide fast, convenient medical information.
In the study presented Oct. 30 at the Acoustical Society of America's annual meeting, researchers determined how well muscles damaged by muscular dystrophy responded to a drug in mice with an animal form of the disease. They did so ...